Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Triclosan never shown to promote antibiotic resistance, SDA says in response to Nature.

This article was originally published in The Tan Sheet

Executive Summary

TRICLOSAN NEVER SHOWN TO PROMOTE ANTIBIOTIC RESISTANCE, SOAP ASSN. says Aug. 10 in response to an in vivo antimicrobial resistance study of the ingredient published in Nature Aug. 6 by Tufts University Center for Adaptation Genetics and Drug Resistance researchers Laura McMurry, PhD, et al. "Antibacterial wash products containing triclosan have been used by consumers and medical professionals in homes and hospitals for more than 30 years," the Soap & Detergent Association said in a joint statement with the Cosmetic, Toiletry & Fragrance Association. "Based on these three decades of research and actual user experience, triclosan has never been shown to promote antibiotic resistance." The associations said they are "fully confident that consumers can safely use antibacterial hand and body wash products."

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel